Pharma Focus America

LEO Pharma and DKSH Partner to Deliver Products and Solutions to People in Asia with Skin Conditions and Thrombosis

Friday, September 30, 2022

DKSH Business Unit Healthcare, a leading partner for healthcare companies looking to expand in Asia and beyond, has formed a strategic partnership with LEO Pharma to bring top-quality therapeutic products for dermatology and thrombosis to patients throughout Asia.

The collaboration between the two companies aims to solidify brand presence, increase market share, and ultimately enhance patient health outcomes in Hong Kong, Malaysia, Singapore, Taiwan, Thailand, Vietnam, and the Philippines. Skin diseases can cause significant physical and social discomfort for millions of patients worldwide, while thrombosis can affect individuals regardless of age, race, gender, or ethnicity.

DKSH will provide comprehensive support to LEO Pharma by establishing dedicated sales and marketing teams in Asia and overseeing logistics and product distribution in these markets. Leveraging its experienced teams and extensive distribution network, DKSH will ensure that LEO Pharma products reach various channels, including modern and traditional trade, hospitals, clinics, and other medical establishments, enabling patients across the region to access the treatments they need.

LEO Pharma, a global company committed to advancing the standard of care for individuals with skin conditions and their families, has made significant advancements in the field of dermatology through decades of research and development. The company offers a wide range of innovative treatments and therapies for various severities of skin diseases, as well as thrombosis.

Khalid Aouidat, Vice President responsible for commercial activities in Southeast Asia at LEO Pharma, expressed his enthusiasm for the partnership, stating that LEO Pharma is dedicated to transforming the standards of care for individuals with skin diseases by introducing new innovative treatments and making them easily accessible. Aouidat believes that DKSH's expertise, strong regional presence in Asia, and sales and marketing capabilities will contribute to strengthening LEO Pharma's brand and facilitating its ongoing growth.

Bijay Singh, Head of Business Unit Healthcare at DKSH, emphasized their commitment to improving healthcare for all and enhancing people's lives. The partnership with LEO Pharma aligns with DKSH's ambition to be the preferred partner for clients, facilitating better access to high-quality and innovative products and solutions for patients in Asia. While DKSH drives LEO Pharma's growth across the region, LEO Pharma can concentrate on research and development efforts to deliver effective products and solutions for individuals with skin conditions.

Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024